116 related articles for article (PubMed ID: 38218365)
1. Tau-S214 Phosphorylation Inhibits Fyn Kinase Interaction and Increases the Decay Time of NMDAR-mediated Current.
Jos S; Poulose R; Kambaru A; Gogoi H; Dalavaikodihalli Nanjaiah N; Padmanabhan B; Mehta B; Padavattan S
J Mol Biol; 2024 Feb; 436(4):168445. PubMed ID: 38218365
[TBL] [Abstract][Full Text] [Related]
2. Systematic profiling of SH3-mediated Tau-Partner interaction network in Alzheimer's disease by integrating in silico analysis and in vitro assay.
Wang X; Chang C; Wang D; Hong S
J Mol Graph Model; 2019 Jul; 90():265-272. PubMed ID: 31112821
[TBL] [Abstract][Full Text] [Related]
3. A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity.
Rush T; Roth JR; Thompson SJ; Aldaher AR; Cochran JN; Roberson ED
Neurobiol Dis; 2020 Feb; 134():104668. PubMed ID: 31698056
[TBL] [Abstract][Full Text] [Related]
4. AlphaScreen HTS and live-cell bioluminescence resonance energy transfer (BRET) assays for identification of Tau-Fyn SH3 interaction inhibitors for Alzheimer disease.
Cochran JN; Diggs PV; Nebane NM; Rasmussen L; White EL; Bostwick R; Maddry JA; Suto MJ; Roberson ED
J Biomol Screen; 2014 Dec; 19(10):1338-49. PubMed ID: 25156556
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau.
Usardi A; Pooler AM; Seereeram A; Reynolds CH; Derkinderen P; Anderton B; Hanger DP; Noble W; Williamson R
FEBS J; 2011 Aug; 278(16):2927-37. PubMed ID: 21692989
[TBL] [Abstract][Full Text] [Related]
6. Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer's disease.
Lau DH; Hogseth M; Phillips EC; O'Neill MJ; Pooler AM; Noble W; Hanger DP
Acta Neuropathol Commun; 2016 May; 4(1):49. PubMed ID: 27193083
[TBL] [Abstract][Full Text] [Related]
7. Disruption of Fyn SH3 domain interaction with a proline-rich motif in liver kinase B1 results in activation of AMP-activated protein kinase.
Yamada E; Bastie CC
PLoS One; 2014; 9(2):e89604. PubMed ID: 24586906
[TBL] [Abstract][Full Text] [Related]
8. Disease-related modifications in tau affect the interaction between Fyn and Tau.
Bhaskar K; Yen SH; Lee G
J Biol Chem; 2005 Oct; 280(42):35119-25. PubMed ID: 16115884
[TBL] [Abstract][Full Text] [Related]
9. The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling.
Arold S; Franken P; Strub MP; Hoh F; Benichou S; Benarous R; Dumas C
Structure; 1997 Oct; 5(10):1361-72. PubMed ID: 9351809
[TBL] [Abstract][Full Text] [Related]
10. Docking and molecular dynamics simulations of the Fyn-SH3 domain with free and phospholipid bilayer-associated 18.5-kDa myelin basic protein (MBP)-Insights into a noncanonical and fuzzy interaction.
Bessonov K; Vassall KA; Harauz G
Proteins; 2017 Jul; 85(7):1336-1350. PubMed ID: 28380689
[TBL] [Abstract][Full Text] [Related]
11. The promiscuous binding of the Fyn SH3 domain to a peptide from the NS5A protein.
Martin-Garcia JM; Luque I; Ruiz-Sanz J; Camara-Artigas A
Acta Crystallogr D Biol Crystallogr; 2012 Aug; 68(Pt 8):1030-40. PubMed ID: 22868769
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.
Reynolds CH; Garwood CJ; Wray S; Price C; Kellie S; Perera T; Zvelebil M; Yang A; Sheppard PW; Varndell IM; Hanger DP; Anderton BH
J Biol Chem; 2008 Jun; 283(26):18177-86. PubMed ID: 18467332
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture.
Miyamoto T; Stein L; Thomas R; Djukic B; Taneja P; Knox J; Vossel K; Mucke L
Mol Neurodegener; 2017 May; 12(1):41. PubMed ID: 28526038
[TBL] [Abstract][Full Text] [Related]
14. Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation.
Mondragón-Rodríguez S; Trillaud-Doppia E; Dudilot A; Bourgeois C; Lauzon M; Leclerc N; Boehm J
J Biol Chem; 2012 Sep; 287(38):32040-53. PubMed ID: 22833681
[TBL] [Abstract][Full Text] [Related]
15. The role of water molecules in the binding of class I and II peptides to the SH3 domain of the Fyn tyrosine kinase.
Camara-Artigas A; Ortiz-Salmeron E; Andujar-Sánchez M; Bacarizo J; Martin-Garcia JM
Acta Crystallogr F Struct Biol Commun; 2016 Sep; 72(Pt 9):707-12. PubMed ID: 27599862
[TBL] [Abstract][Full Text] [Related]
16. A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein.
Lee CH; Leung B; Lemmon MA; Zheng J; Cowburn D; Kuriyan J; Saksela K
EMBO J; 1995 Oct; 14(20):5006-15. PubMed ID: 7588629
[TBL] [Abstract][Full Text] [Related]
17. Isolation of monobodies that bind specifically to the SH3 domain of the Fyn tyrosine protein kinase.
Huang R; Fang P; Kay BK
N Biotechnol; 2012 Jun; 29(5):526-33. PubMed ID: 22155429
[TBL] [Abstract][Full Text] [Related]
18. miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.
Liu W; Zhao J; Lu G
Biochem Biophys Res Commun; 2016 Sep; 478(2):852-7. PubMed ID: 27520374
[TBL] [Abstract][Full Text] [Related]
19. An SH3 binding motif within the nucleocapsid protein of porcine reproductive and respiratory syndrome virus interacts with the host cellular signaling proteins STAMI, TXK, Fyn, Hck, and cortactin.
Kenney SP; Meng XJ
Virus Res; 2015 Jun; 204():31-9. PubMed ID: 25882913
[TBL] [Abstract][Full Text] [Related]
20. Novel Src homology 3 domain-binding motifs identified from proteomic screen of a Pro-rich region.
Jia CY; Nie J; Wu C; Li C; Li SS
Mol Cell Proteomics; 2005 Aug; 4(8):1155-66. PubMed ID: 15929943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
